Skip to main content
All lobbying filings

Tiber Creek Group

Tiber Creek Group filed a Q1 report for Astrazeneca on April 18, 2026, reporting $80,000 in lobbying income.

Lobbying for Astrazeneca

As filed: TIBER CREEK GROUP for ASTRAZENECA.

All filings by Tiber Creek Group · Everything Astrazeneca has reported

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 18, 2026
Income
$80,000
What the client paid this registrant for the period.

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2
Medicare/Medicaid

Issues related to Medicare Part D and Part B Pricing Reform; Issues related to the Medicaid Pricing reform; Issues related to H.R. 946/S. 1862 - ORPHAN Cures Act.

Health Issues

Issues related to the 340B Program - Public Health Service Act (PL 78-410).

 Bills named in this filing 2

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem